Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Change in Account Payables came in at $380240.0 in Q1 2026, up 296.81% YoY from $95824.0 in Q1 2025, and up 186.42% on a QoQ basis from -$439992.0 in Q4 2025.
Neuroone Medical Technologies (NMTC) Change in Account Payables (2016 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has 10 years of Change in Account Payables data on file, last reported at $380240.0 in Q1 2026.
- Quarterly Change in Account Payables rose 296.81% year-over-year to $380240.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99346.0 (up 39.97% YoY) and the FY2025 annual result came in at $239983.0, up 258.22% from the prior year.
- Change in Account Payables climbed to $380240.0 in Q1 2026, from -$439992.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $602635.0 in Q3 2022 to a low of -$439992.0 in Q4 2025.
- A 5-year average of $13194.2 and a median of -$14939.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 3746.27% in 2025, down 2845.26% in 2025.
- Tracing NMTC's Change in Account Payables over 5 years: stood at -$154098.0 in 2022, then surged by 151.61% to $79527.0 in 2023, then tumbled by 118.78% to -$14939.0 in 2024, then plunged by 2845.26% to -$439992.0 in 2025, then jumped by 186.42% to $380240.0 in 2026.
- The last three Change in Account Payables figures came in at $380240.0 (Q1 2026), -$439992.0 (Q4 2025), and $526943.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | - |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Neuroone Medical Technologies | 19.73 Mn | 17.68 Mn | 1.18 Mn | -33,326.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -33,326.00 |
| Jun 30, 2026 | -33,326.00 |
| Mar 31, 2026 | 380,240.00 |
| Mar 31, 2026 | 380,240.00 |
| Dec 31, 2025 | -439,992.00 |
| Dec 31, 2025 | -439,992.00 |
| Sep 30, 2025 | 526,943.00 |
| Sep 30, 2025 | 526,943.00 |
| Jun 30, 2025 | -367,845.00 |
| Jun 30, 2025 | -367,845.00 |
| Mar 31, 2025 | 95,824.00 |
| Mar 31, 2025 | 95,824.00 |
| Dec 31, 2024 | -14,939.00 |
| Dec 31, 2024 | -14,939.00 |
| Sep 30, 2024 | 22,206.00 |
| Sep 30, 2024 | 22,206.00 |
| Jun 30, 2024 | -32,112.00 |
| Jun 30, 2024 | -32,112.00 |
| Mar 31, 2024 | -2,628.00 |
| Mar 31, 2024 | -2,628.00 |